Updated on: February 2, 2018

News Alert: DOJ Memo Brings Promising News for Providers Facing Government Action

By
Original story posted on: February 1, 2018

  • Product Headline: Limiting use of the Agency Guidance Documents in Affirmative Enforcement Cases
  • Product Image: Product Image
  • Product Description:

    DOJ MEMORANDUM

Those investigating healthcare entities instructed to stick to statutes and regulations

The U.S. Department of Justice (DOJ) has issued another memo likely to help healthcare providers avoid potentially unfair government investigations. 

The Jan. 25 memo from Associate Attorney General Rachel Brand to the heads of all civil litigation components and U.S. Attorney’s offices instructs the government lawyers to refrain from using government “guidance documents” when bringing a case. (When this happens, it is often referred to as “affirmative civil enforcement,” or ACE)

The most common form of affirmative civil enforcement in the healthcare industry are False Claims Act cases, but any civil investigation by the government would also qualify. The memo reads that the government should base its cases on statutes and regulations, not less formal agency guidance. 

In the context of healthcare, the Medicare Manuals and bulletins issued by Medicare Administrative Contractors (MACs) are all considered guidance. As such, this memo means that when a U.S. Attorney’s office brings a case, it should not base its case on anything in the Manuals or MAC guidance; it must premise the claim on the appropriate federal statutes and regulations.    

The memo also says that the government may use the guidance for “proper purposes,” like explaining a legal mandate, and it may also use the fact that someone read the Manuals to show that the person had an intent to violate the law. But the text of a Manual should not be the basis of a government lawsuit.

While this is likely good news for those handling False Claims Act cases, it is important to note that the memo does not render the Manuals irrelevant. Because the memo is only direct to people within the Department of Justice (DOJ), the memo is unlikely to have impact on Medicare overpayment cases until the overpayment case reaches District Court, the level above the Medicare Appeals Council (which is the level above the Administrative Law Judges, or ALJs.) In short, MACs may still try to point to language in the Medicare Manuals to try to recover a Medicare overpayment. Healthcare professionals still can and should argue that the Manuals are not binding. 

The memo also applies in civil cases, and at least some government lawyers have suggested that they will not apply the same thinking in criminal cases. That position is a bit surprising because one could argue that the new DOJ memo should not be news; government agencies are only supposed to use guidance to explain regulation, not to create new rules. Under longstanding law, policies that don’t go through proper notice and comment are not supposed to be binding. However, courts have often given agencies considerable leeway in interpreting regulations. This has resulted in government Manuals getting deference from the courts in some cases. There is a real possibility that the memo will begin to reverse that trend. 

This memo comes shortly after Michael Granston, Director of the Civil Fraud Division at the DOJ, issued a memo instructing U.S. Attorneys to consider dismissing meritless False Claims Act cases. Taken together, the memos may suggest that healthcare professionals will be a bit less likely to face a lengthy court battle over issues that aren’t explicitly covered by a federal law or regulation.

Program Note:

Listen to David Glaser report on this story this coming Monday on Monitor Mondays.

David M. Glaser, Esq.

David M. Glaser, Esq., is a shareholder in Fredrikson & Byron’s Health Law Group. David helps clinics, hospitals, and other healthcare entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David’s goal is to explain the government’s enforcement position and to analyze whether the law supports this position. David is a popular panelist on Monitor Mondays and a member of the RACmonitor editorial board.

 

This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles

  • News Alert: CMS Orders Halt to Loan Repayment
    Action applies to the Medicare Accelerated and Advanced Payment Loan Program.  In March, the Centers for Medicare & Medicaid Services (CMS) expanded the Accelerated and Advanced Payment Program (AAP) due to the COVID-19 public health emergency (PHE), in an effort to…
  • New Settlement Demonstrates New Fraud Type in Medicare Advantage program – Inflation of bids
    Two payers allegedly inflated their bids. Earlier this month, two Independence Blue Cross (IBC) subsidiaries in Pennsylvania agreed to pay $2.25 million to resolve allegations that they defrauded the Medicare Advantage (MA) program and violated the False Claims Act by…
  • The Audit Algorithm Arms Race in Medicare
    Providers forced to camouflage in mediocrity.  EDITOR’S NOTE: This the first in a series of articles that explores the use of algorithms in the auditing of medical claims. The Centers for Medicare & Medicaid Services (CMS) has pioneered the use of…